Comorbidities, Age, and Outcomes Among Intensively Treated Patients With AML

Special Reports, Hematologic Malignancies, Volume 1, Issue 1

Timothy S. Pardee, MD, discusses comorbidities, age, and outcomes among intensively treated patients with acute myeloid leukemia (AML).

Timothy S. Pardee, MD, assistant professor, Hematology & Oncology, Wake Forest University Baptist Medical Center, discusses comorbidities, age, and outcomes among intensively treated patients with acute myeloid leukemia (AML).

Read about new treatments for AML > >